tradingkey.logo
tradingkey.logo
Search

Galapagos NV

GLPG
Add to Watchlist
27.730USD
0.0000.00%
Close 07/01, 16:00ETQuotes delayed by 15 min
1.95BMarket Cap
4.32P/E TTM

TradingKey Stock Score of Galapagos NV

Currency: USD Updated: 2026-05-07

Key Insights

Galapagos NV's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 100 out of 385 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Sell, with the highest price target at 28.00.In the medium term, the stock price is expected to trend down.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Galapagos NV's Score

Industry at a Glance

Industry Ranking
100 / 385
Overall Ranking
210 / 4498
Industry
Biotechnology & Medical Research

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Galapagos NV Highlights

StrengthsRisks
Galapagos NV is a Belgium-based clinical-stage biotechnology company. The Company is engaged in the discovery and development of small molecule medicines with modes of action. Its pipeline comprises Phase 3, 2, 1, pre-clinical studies and discovery small-molecule and antibody programs in cystic fibrosis, inflammation, and other indications. The Company focuses on developing a portfolio of clinical-stage therapies for the enhancement of existing treatment paradigms. It develops transformational medicines in areas of high unmet need by combining internal with external science with the goal to add years of life and improve of life of patients across the globe. It discovers which proteins that are involved in causing diseases such as, rheumatoid, arthritis, inflammatory bowel disease and fibrosis. The Company acquired CellPoint and AboundBio in order to develop a cell therapy, which is a potential transformative treatment of different types of cancer.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 326.60% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 944.91M.
Fairly Valued
The company’s latest PE is 4.32, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 14.96M shares, decreasing 32.12% quarter-over-quarter.
Held by Invesco
Star Investor Invesco holds 872.00 shares of this stock.

Analyst Rating

Based on 3 analysts
Sell
Current Rating
28.000
Target Price
-6.60%
Upside Space

FAQs

How does TradingKey generate the Stock Score of Galapagos NV?

The TradingKey Stock Score provides a comprehensive assessment of Galapagos NV based on 34 indicators derived from over 100 underlying data points.
These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of Galapagos NV’s performance and outlook.

How do we generate the financial health score of Galapagos NV?

To generate the financial health score of Galapagos NV, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns.
By integrating these comprehensive data, the financial health score not only reflects Galapagos NV's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of Galapagos NV.

How do we generate the company valuation score of Galapagos NV?

To generate the company valuation score of Galapagos NV, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare Galapagos NV’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value.
By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of Galapagos NV’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of Galapagos NV.

How do we generate the earnings forecast score of Galapagos NV?

To calculate the earnings forecast score of Galapagos NV, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:
Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.
Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.
By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.
Comparing these indicators against peers provides context for the stock’s performance and helps anchor more realistic expectations.
These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on Galapagos NV’s future.

How do we generate the price momentum score of Galapagos NV?

When generating the price momentum score for Galapagos NV, we examine momentum indicators including support and resistance levels as well as volume metrics.
Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.
This comprehensive approach can reflect market sentiment and enable rational forecasts of Galapagos NV’s prices. A higher score indicates a more stable short-term price trend for Galapagos NV.

How do we generate the institutional confidence score of Galapagos NV?

To generate the institutional confidence score of Galapagos NV, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about Galapagos NV’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of Galapagos NV.

How do we generate the risk management score of Galapagos NV?

To assess the risk management score of Galapagos NV, we examine multiple key indicators related to returns, risk, volatility, and liquidity.
The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.
These indicators together provide a multi-dimensional understanding of Galapagos NV’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of Galapagos NV.